These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1310671)

  • 1. Detection of ciprofloxacin resistance in gram-negative bacteria due to alterations in gyrA.
    Power EG; Muñoz Bellido JL; Phillips I
    J Antimicrob Chemother; 1992 Jan; 29(1):9-17. PubMed ID: 1310671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.
    Heisig P; Wiedemann B
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2031-6. PubMed ID: 1759823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing.
    Charvalos E; Peteinaki E; Spyridaki I; Manetas S; Tselentis Y
    J Clin Lab Anal; 1996; 10(3):129-33. PubMed ID: 8731499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli.
    Sreedharan S; Oram M; Jensen B; Peterson LR; Fisher LM
    J Bacteriol; 1990 Dec; 172(12):7260-2. PubMed ID: 2174869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluoroquinolones and Gram-negative bacteria: antimicrobial activity and mechanisms of resistance].
    Luzzaro F
    Infez Med; 2008 Apr; 16 Suppl2():5-11. PubMed ID: 18843219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antibacterial activity of fluoroquinolones against gram-negative bacteria isolated from Gifu Prefecture (2005)].
    Tanaka T; Mitsuyama J; Yamaoka K; Asano Y; Hashido H; Matsukawa Y; Matsubara S; Sawamura H; Suematsu H; Terachi M; Miyabe T; Mikamo H; Watanabe K;
    Jpn J Antibiot; 2007 Jun; 60(3):141-52. PubMed ID: 17867488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR; Tapsall JW; White PA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X; Lind I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.
    Aleixandre V; Herrera G; Urios A; Blanco M
    Antimicrob Agents Chemother; 1991 Jan; 35(1):20-3. PubMed ID: 1849710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes.
    Park YH; Yoo JH; Huh DH; Cho YK; Choi JH; Shin WS
    Yonsei Med J; 1998 Dec; 39(6):534-40. PubMed ID: 10097680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorhexidine hypersensitivity of ciprofloxacin-resistant variants of Pseudomonas aeruginosa PAO.
    Baillie LW; Power EG; Phillips I
    J Antimicrob Chemother; 1993 Feb; 31(2):219-25. PubMed ID: 8385092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens.
    Zlamal JE; Leyn SA; Iyer M; Elane ML; Wong NA; Wamsley JW; Vercruysse M; Garcia-Alcalde F; Osterman AL
    mBio; 2021 Jun; 12(3):e0098721. PubMed ID: 34154405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro ciprofloxacin resistance profiles among gram-negative bacteria isolated from clinical specimens in a teaching hospital.
    Akhtar N; Alqurashi AM; Abu Twibah M
    J Pak Med Assoc; 2010 Aug; 60(8):625-7. PubMed ID: 20726190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.
    Bachoual R; Tankovic J; Soussy CJ
    Microb Drug Resist; 1998; 4(4):271-6. PubMed ID: 9988045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-host-range gyrase A gene probe.
    Robillard NJ
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1889-94. PubMed ID: 1963286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus.
    Tankovic J; Duval J; Courvalin P
    FEMS Immunol Med Microbiol; 1994 Jun; 9(1):35-9. PubMed ID: 7920462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of quinolone resistance.
    Wiedemann B; Heisig P
    Infection; 1994; 22 Suppl 2():S73-9. PubMed ID: 7927834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.